Launch One Acquisition Corp..
LPAA.US | Activities of holding companies
Launch One Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the company may pursue an initial business combination target in an...Show More
Better Health for All
20
Minovia Therapeutics, the target company for LPAA.US, is entirely devoted to health improvement through its lead product, MNV-201.
1
This mitochondrial cell therapy aims to restore organ function and improve health in patients with severe mitochondrial diseases like Pearson Syndrome, low-risk Myelodysplastic Syndrome, Kearns-Sayre, and Leigh syndromes.
2
Early-stage clinical studies involving 23 patients have shown exceptional health benefits, including improvements in growth, muscle function, hematologic stability, and quality of life.
3
The company's products do not have established negative health outcomes.
4
Furthermore, MNV-201 has demonstrated an outstanding safety profile in these early-stage clinical studies, with no drug-product related adverse responses reported for the 23 patients.
5
Fair Money & Economic Opportunity
0
Launch One Acquisition Corp. (LPAA.US) is a blank check company formed for the purpose of effecting a business combination, as evidenced by its recent initial public offering (IPO) of 20,000,000 units.
1
As a blank check company, it does not currently offer lending, deposit, or other financial services or products to consumers. Therefore, all Key Performance Indicators related to fair money and economic opportunity, which assess financial institutions' impact on consumers and underserved populations, are not applicable to LPAA.US at this stage.
Fair Pay & Worker Respect
0
No specific, quantitative data for LPAA.US related to any of the 'Fair Pay & Worker Respect' KPIs was found in the provided articles.
1
The articles discuss other companies or general industry trends, but do not provide information on LPAA.US's living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Launch One Acquisition Corp. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Launch One Acquisition Corp. on Honest & Fair Business.
Kind to Animals
0
The company, Minovia Therapeutics, which Launch One Acquisition Corp. is merging with, uses aged animal models and mouse models for preclinical studies to evaluate its Mitochondrial Augmentation Technology (MAT).
1
However, the provided articles do not offer specific quantitative data on the number of animals used annually, the extent of non-animal testing methods employed, or details regarding any animal testing policies. Therefore, no KPIs can be scored based on the available evidence.
No War, No Weapons
0
Launch One Acquisition Corp. (LPAA.US) has entered into a definitive business combination agreement with Minovia Therapeutics Ltd., a clinical-stage biotechnology company.
1
The combined entity will focus on developing and commercializing Minovia's mitochondrial augmentation technology for medical conditions.
2
The provided articles contain no evidence of LPAA.US or Minovia Therapeutics being involved in arms manufacturing, military contracts, dual-use technology, sales to embargoed regimes, or any other activities related to war or weapons. Therefore, all KPIs are scored as N/A, indicating no defense or arms-related activities in their core business.
Planet-Friendly Business
0
Launch One Acquisition Corp. (LPAA.US) is a blank check company (SPAC).
1
The provided articles detail its Initial Public Offering (IPO), proposed merger agreements (which were later terminated), and financial information. None of the articles contain any specific, concrete data points or facts related to environmental performance, climate initiatives, resource consumption, waste management, or any other planet-friendly business practices. Therefore, no KPIs can be scored based on the evidence provided.
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles to assess LPAA.US against any of the KPIs for the 'Respect for Cultures & Communities' ethical value. The articles primarily consist of press releases and corporate announcements that explicitly state a lack of information regarding the company's operations, community engagement, or social responsibility metrics.
1
Safe & Smart Tech
0
No specific evidence was found in the provided articles regarding LPAA.US's performance across any of the Safe & Smart Tech KPIs. The articles discuss general industry trends, risks, and regulatory landscapes within the healthcare and life sciences sectors, particularly concerning data breaches, AI ethics, and cybersecurity, but do not provide concrete data points or actions attributable to LPAA.US, which is a blank check company intending to focus on space exploration, satellite, and related industries.
Zero Waste & Sustainable Products
0
No specific, concrete data points or initiatives related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audits, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles for LPAA.US or Minovia Therapeutics.
1